Data as of .
BIOY vs SOXY: which paid, and which earned it?
BIOY and SOXY both write options for income.
What they hold in common
By the books each fund has filed, BIOY and SOXY hold 0% of their money in the same securities at the same weight.
| Only in BIOY | Only in SOXY |
|---|---|
| Treasury Bill 100.00% | NVIDIA Corp 6.54% |
| Advanced Micro Devices Inc 6.01% | |
| MARVELL TECHNOLOGY INC 5.73% | |
| Micron Technology Inc 5.10% | |
| United Microelectronics Corp 4.92% | |
| ASML Holding NV 4.75% | |
| Broadcom Inc 4.38% | |
| ARM Holdings PLC 4.36% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and Sep 21, 2026.
Performance, window by window
| Window | Total return | Cash paid | Against the benchmark | |||
|---|---|---|---|---|---|---|
| BIOY | SOXY | BIOY | SOXY | BIOY | SOXY | |
| 3 months | +2.5% | −16.9% | 14.1% | 2.5% | −9.0 pts | −3.7 pts |
| 6 months | not published | +52.4% | not published | 8.4% | not published | +3.5 pts |
| 1 year | not published | +84.9% | not published | 16.4% | not published | +3.5 pts |
| Since launch | +2.0% | +123.2% | 20.6% | 26.9% | −15.3 pts | −9.2 pts |
| BIOY GraniteShares YieldBOOST Biotech ETF Synthetic covered call on XBI, paying weekly | SOXY YieldMax(R) Target 12(TM) Semiconductor Option Income ETF Synthetic covered call on SMH, paying monthly | |
|---|---|---|
| Issuer | GraniteShares | YieldMax |
| Strategy | synthetic covered call | synthetic covered call |
| Benchmark | Biotech (XBI), used as the proxy | Semiconductors (SMH) |
| Pays | weekly | monthly |
| Payout rate, annualized | 60.0% | 11.7% |
| Expense ratio | 1.07% | 1.06% |
| Cash paid, 1 year | 20.6% (since launch on May 5, 2026) | 16.4% |
| Price change, 1 year | −19.0% | +64.1% |
| Total return, 1 year | +2.0% (since launch on May 5, 2026) | +84.9% |
| Benchmark return, 1 year | +17.3% | +81.3% |
| Ahead or behind | −15.3 pts | +3.5 pts |
| Return of capital, latest estimate | 96% | 95% |
| Age | 136 days | 654 days |
| Net assets | $1m | $66m |
BIOY in plain words
Over the period since launch on May 5, 2026 to Sep 18, 2026, BIOY paid 20.6% of its starting value in cash distributions while its price fell 19.0%. With every distribution reinvested, the fund returned +2.0%. Biotech (XBI), used as the proxy returned +17.3% over the same days, so a holder was behind by 15.3 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 60.0%, paid weekly. GraniteShares estimates that 96% of the distribution paid Aug 25, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
SOXY in plain words
Over the year to Sep 18, 2026, SOXY paid 16.4% of its starting value in cash distributions while its price rose 64.1%. With every distribution reinvested, the fund returned +84.9%. Semiconductors (SMH) returned +81.3% over the same days, so a holder was ahead by 3.5 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 11.7%, paid monthly. YieldMax estimates that 95% of the distribution paid Sep 3, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
Questions people ask
- Which is cheaper, BIOY or SOXY?
- BIOY charges 1.07% a year and SOXY charges 1.06%, so SOXY is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, BIOY against SOXY, data as of Sep 18, 2026. https://etfiq.com/compare/income/bioy-vs-soxy Free to use with attribution; the underlying files are at Open data.